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Since Monro published his observations on the nature of the contents of the intracra-
nial space in 1783, there has been investigation of the unique relationship between the
contents of the skull and the intracranial pressure (ICP). This is particularly true follow-
ing traumatic brain injury (TBI), where it is clear that elevated ICP due to the underlying
pathological processes is associated with a poorer clinical outcome. Consequently, there
is considerable interest in monitoring and manipulating ICP in patients with TBI. The two
techniques most commonly used in clinical practice to monitor ICP are via an intraventricu-
lar or intraparenchymal catheter with a microtransducer system. Both of these techniques
are invasive and are thus associated with complications such as hemorrhage and infec-
tion. For this reason, significant research effort has been directed toward development of
a non-invasive method to measure ICP. The principle aims of ICP monitoring in TBI are to
allow early detection of secondary hemorrhage and to guide therapies that limit intracra-
nial hypertension (ICH) and optimize cerebral perfusion. However, information from the ICP
value and the ICP waveform can also be used to assess the intracranial volume–pressure
relationship, estimate cerebrovascular pressure reactivity, and attempt to forecast future
episodes of ICH.
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INTRODUCTION
The pathophysiology of traumatic brain injury (TBI) can be
divided into primary and secondary injury. The primary injury
may include focal hematomas, contusions, or diffuse injury that
leads to a cycle of hypoxic ischemic injury associated with
inflammatory and neurotoxic processes (Figure 1). This sec-
ondary injury is exacerbated by secondary physiological insults
such as hypoxia, hypo- or hypercarbia, hypotension, hyper-
thermia, and hypo- or hyperglycemia. A rise in intracranial
pressure (ICP), or intracranial hypertension (ICH), is a sec-
ondary insult that can result from the primary injury, vas-
cular engorgement, obstruction to cerebrospinal fluid (CSF)
flow or cerebral edema. It is known to be associated with
poorer outcomes (1), which has led to considerable inter-
est in its monitoring and manipulation in patients who have
suffered TBI.
Normal ICP in healthy adults is usually regarded as 5–15 mmHg
(3) and in TBI an ICP of >20 mmHg is widely accepted as ICH
(4). The principle aims of ICP monitoring in TBI are to allow
early detection of secondary hemorrhage and to guide thera-
pies that limit ICH. In addition, measurement of ICP and mean
arterial pressure (MAP) allows calculation of cerebral perfusion
pressure (CPP):
CPP = MAP− ICP (1)
Attempts can then be made to optimize CPP with the aim of
preventing cerebral ischemia.
There is ongoing debate over the central role of ICP monitoring
in the clinical management of TBI. This is particularly relevant in
the context of a recent randomized controlled trial (RCT) that did
not show an outcome benefit in patients undergoing ICP moni-
toring with a treatment threshold of 20 mmHg when compared to
patients that were not monitored (5). The purpose of this review
is therefore to reconsider some of the basic science underlying ICP
monitoring and the ICP–volume relationship in adults. With this
pretext, we will then support the arguments of other authors for
the use of ICP as “more than a number” or a generic treatment
threshold (6). Instead, the information within ICP trends and the
ICP waveform can be used to provide individualized treatment
thresholds and forecast future episodes of ICH.
CONCEPTS AND HISTORICAL PERSPECTIVE
INTRACRANIAL CONTENTS
The Monro–Kellie hypothesis describes the relationship between
the contents of the skull (7). In 1783, Monro published his obser-
vations that: the brain was enclosed in a non-expandable case of
bone; the substance of the brain was nearly incompressible; the
volume of the blood in the cranial cavity was therefore constant or
nearly constant; and a continuous outflow of venous blood from
the cranial cavity was required to make room for the continuous
incoming arterial blood. Experiments performed by Kellie and
Abercrombie supported these observations but they, like Monro,
did not account for the role of CSF.
As the important role of CSF was recognized, the Monro–
Kellie hypothesis was revised to its current form where with an
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FIGURE 1 |The inter-relationship between primary and secondary injury inTBI is shown. Secondary physiological insults can potentiate ischemia and lead
to exacerbation of secondary injury. ICP= intracranial pressure, adapted from Mass et al. (2).
intact skull, the sum of the volumes of the brain, intracranial
blood, and CSF are constant. Therefore, an increase in one neces-
sitates a decrease in one or both of the remaining two. As the
brain parenchyma is essentially non-compressible, compensation
is achieved through extrusion of CSF or venous blood.
INTRACRANIAL PRESSURE MEASUREMENT
Lundberg systematically described the technique of continuous
ICP monitoring using an intraventricular catheter in a series of
130 patients with suspected intracranial space occupying lesions
(8). He then went on to confirm the feasibility of the technique in
a series of 30 patients with TBI (9).
In his seminal paper, Lundberg identified three typical patterns
of ICP fluctuation, which have come to be known as “A,” “B,” and
“C” waves. A waves are steep rises in ICP to a plateau of 50 mmHg
or more and are sustained for 5–20 min before falling rapidly. They
represent a critical reduction in intracranial compliance. B waves
occur with a frequency of 0.5–2 Hz and are rhythmic oscillations to
20–30 mmHg above the baseline but without a sustained period of
ICH. C waves are not thought to be of pathophysiological impor-
tance, probably a reflection of Traube–Hering waves originating
in the arterial pressure and are of much smaller amplitude to B
waves.
While Lundberg and colleagues were developing the role of ICP
monitoring in man, Langfitt’s group were examining primates
to carefully characterize the transmission of pressure across the
intracranial compartments (10, 11). The phenomenon of pres-
sure underestimation was fully defined in experimental studies of
extradural brain compression where progressive loss of transmis-
sion of ICP across the tentorial hiatus occurred, with the pressure
in the posterior fossa and lumbar subarachnoid space progressively
under-reading the ventricular pressure and eventually returning to
normal pressure.
EXPLORING THE INTRACRANIAL VOLUME–PRESSURE RELATIONSHIP
The intracranial volume–pressure curve demonstrates how small
increase in volume of one of the intracranial components can be
compensated by a reduction in CSF or blood volume (Figure 2).
However, these compensatory measures are quickly exhausted and
any subsequent increase in volume leads to an exponential increase
in ICP. Measurement of this volume–pressure relationship is most
often incorrectly referred to as intracranial compliance. According
to conventional terminology, it should be referred to as elastance
(change in pressure per unit change in volume,∆P/∆V ) (12, 13).
Due to the exponential nature of the volume–pressure relation-
ship as depicted in Figure 2, being able to quantify elastance is
attractive clinically as, in theory, it will increase during the volume
compensation phase more rapidly than ICP and should therefore
be predictive of impending volume decompensation.
The first full mathematical description of the craniospinal
volume–pressure relationship was published by Marmarou in 1973
(14). Since then, several research groups have contributed physio-
logical simulation models of ICP dynamics of varying complexity.
These models aim to improve understanding of ICP pathophysi-
ology and thus assist in the development of appropriate treatment
strategies. A detailed comparative review on this subject has been
provided by Wakeland and Goldstein (15). The early work of
Marmarou and colleagues shall be discussed below as it provides
an introduction to many important concepts surrounding ICP
dynamics.
Through his interest in the pathological state of hydrocephalus,
Marmarou developed a mathematical model of the CSF system
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that produced a general solution for the CSF pressure (14). The
model parameters were verified experimentally in a series of exper-
iments on adult cats (16). In these studies, the CSF pressure was
measured both intracranially at the cisterna magna and in the
lumbar subarachnoid space in response to bolus injections. Of
particular note in this work, was the introduction of the pressure–
volume index (PVI). Marmarou confirmed the non-linear rela-
tionship between changes in craniospinal volume and pressure.
However, by plotting changes in volume against the log of pres-
sure, a straight-line relationship could be defined (Figure 3). The
slope of this line is termed the PVI and is the notional volume
required to raise ICP 10-fold. Unlike elastance or compliance, the
ICP 
Volume 
Compensated 
Phase 
Decompensated 
Phase 
FIGURE 2 | Cerebral volume–pressure curve showing the exponential
relationship between ICP and an increase in volume of one of the
intracranial components.
PVI characterizes the craniospinal volume–pressure relationship
over the whole physiological range of ICP.
Calculation of the PVI by measuring the pressure change in
response to a rapid injection or withdrawal of fluid from the sub-
arachnoid space has previously been used both experimentally and
clinically as a measure of craniospinal elastance (17–21). Shapiro
found that a PVI reduced by 80% of control values was predictive
of raised ICP in pediatric TBI (22). Similarly, Tans and Poortvliet
measured PVI in adults with a range of brain injuries, including
TBI, and demonstrated that a reduced index was associated with
impending ICH (23).
Marmarou’s mathematical model developed an improved
understanding not only of craniospinal elastance but also of the
inter-relationships of the static and dynamic processes of for-
mation, storage, and absorption of CSF. Previously, Davson had
demonstrated that by withdrawing CSF at the estimated rate of
CSF production (approximately 0.3 ml/min), it was possible to
determine the cerebral venous pressure (24). This value could then
be substituted into the steady-state ICP equation:
ICP = Pssp + (If × Ro) (2)
where P ssp is cerebral venous pressure, I f is CSF formation rate,
and Ro is CSF outflow resistance. Marmarou extended Davson’s
work and his general solution for ICP allowed the derivation of
an equation for CSF outflow resistance based on a bolus injection
technique (Figure 4) (14, 16).
In TBI management, it is useful to know CSF outflow resis-
tance when determining the etiology of raised ICP. In general
terms, causes of ICH can be categorized into “vascular” and
“non-vascular” mechanisms. Vascular mechanisms include active
cerebral vasodilation due to stimuli such as increased arterial
FIGURE 3 | Log ICP vs. intracranial volume relationship defined by Marmarou (14). The pressure–volume index (PVI) is the notional volume (milliliters),
which when added to the craniospinal volume causes a 10-fold rise in ICP.
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FIGURE 4 | Formulas for deriving the pressure–volume index (PVI),
volume–pressure response (VPR), and the CSF outflow resistance (Ro),
where P 0 is the baseline CSF pressure, P p is the peak pressure
resulting from a bolus volume injectionV 0, and P 2 refers to the
pressure point on the return trajectory at time t 2.
carbon dioxide levels or decreased CPP with intact pressure
autoregulation, passive distension of cerebral vessels in the absence
of autoregulation or venous outflow obstruction. Non-vascular
mechanisms include increased brain mass due to cerebral edema
or an expanding extradural, subdural, or intracerebral mass. A
further non-vascular mechanism is an increase in CSF outflow
resistance secondary to obstruction of the normal CSF pathway.
The importance of vascular factors and the state of cerebral
blood flow (CBF) autoregulation as a determinant of craniospinal
elastance was shown clearly by the work of Gray and Rosner (25,
26). The autoregulation of CBF will be discussed later, however,
through a series of studies in adult cats, Gray and Rosner demon-
strated that with CPP levels >50 mmHg, there was a linear increase
in PVI with increasing CPP. Similarly, with CPPs below 50 mmHg,
further reduction in CPP was also associated with increased PVI,
as well as reduced CBF. This work illustrated that the PVI is a
complex function of CPP and that the direction of the CPP–
PVI relationship is dependent on whether CPP is above or below
the autoregulatory range for CBF. The importance of the state of
autoregulation on PVI has been supported recently by Lavinio et al.
(27). In a series of brain-injured patients admitted to the inten-
sive care unit (ICU), PVI results were significantly different if a
transcranial Doppler (TCD) derived assessment of middle cere-
bral artery (MCA) flow velocity (FV) revealed defective cerebral
autoregulation.
Despite the potential for providing valuable information on
the ICP–volume relationship, the PVI is not routinely measured in
clinical management of severe TBI. Variability between measure-
ments is high because of the difficulty in rapid manual injection
at a constant rate. As a result, an average of repeated measures is
usually required. In addition, there is an infection risk associated
with injecting fluid into the subarachnoid space via an intraven-
tricular catheter (28–30) and a risk of provoking secondary ICP
rises following injection as a consequence of vasodilation (31).
Thus, an interest in deriving estimates of the ICP–volume rela-
tionship indirectly through analysis of the ICP waveform has
become a research focus.
ICP WAVEFORM
The ICP waveform has three consistent peaks that are related to the
arterial pulse waveform (Figure 5), although their exact etiology is
the subject of some debate (32). Avezaat and van Eijndhoven sys-
tematically studied the ICP waveform pulse amplitude (ICPplse)
as a measure of craniospinal elastance (31, 33). In recognition of
the limitations of the PVI, related to the need for volume injec-
tion or withdrawal, they exploited the fact that with each cardiac
cycle there is a pulsatile increase in cerebral blood volume. This
is the equivalent of a small intracranial volume injection, and the
ICPplse is the pressure change in response to that volume increment
and should consequently be directly related to the craniospinal
elastance (dP/dV ). Therefore, as craniospinal elastance increases
(compliance decreases) the ICPplse should increase. The obser-
vation that as ICP increases so does the amplitude of the ICP
pulsations is not a new one, having been first described in 1866 by
Leyden (34).
The mathematical description of the exponential craniospinal
volume–pressure relationship was extended by Avezaat and Van
Eijndhoven through the introduction of a constant term P0 into
the pressure–volume equation. Primarily for mathematical con-
venience, this term shifts the volume–pressure curve as a whole
up or down its axis, which allows for correction of pressure trans-
ducer reference position and postural changes. Mathematically,P0
is the pressure at zero elastance (Figure 6) and must therefore have
physiological significance as a determinant of the normal intracra-
nial equilibrium pressure (Peq). Löfgren showed that alterations
in central venous pressure (CVP) can shift the pressure–volume
curve up or down its axis (35), which would suggest CVP may be
a factor determining P0.
To allow validation of ICPplse as a measure of elastance, Avezaat
and Van Eijndhoven compared the relationship of ICPplse versus
ICP and elastance, as invasively measured by volume injection,
versus ICP. This was performed in a series of 58 patients under-
going ICP monitoring for a variety of neurosurgical indications.
A linear relationship between both ICPplse and ICP and invasively
measured elastance and ICP was confirmed, supporting the mono-
exponential relationship between intracranial volume and ICP.
However, the correlation between these relationships was weak.
Of particular note in the above study was the observation that
there was a disproportionate increase in ICPplse during plateau
waves, which was felt secondary to an increase in dV due to
defective cerebral vascular muscle tone. To explore this phenom-
enon further they monitored ICPplse while manipulating ICP in
adult dogs by inflating an epidural balloon. They found that the
ICPplse increased linearly with ICP up until a pressure of 60 mmHg
(Figure 7). At this pressure a breakpoint occurred and the ICPplse
increased more rapidly with increasing ICP. It was postulated that
the breakpoint marked the loss of CBF autoregulation, which will
be dealt with in more detail below.
The major limitation of using ICPplse as a measure of cran-
iospinal elastance (dP/dV) is the need to assume that the volume
of pulsatile blood (dV) is constant. This is unlikely to be the case in
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FIGURE 5 | ICP waveform recorded from a Raumedic intraparenchymal catheter and displayed beneath an arterial waveform recorded from the radial
artery in a patient withTBI. CRAN= intracranial pressure, ABP= arterial blood pressure, P 1 = percussion wave, P 2 = tidal wave, P 3 =dicrotic wave.
FIGURE 6 | Volume–pressure relationship and equation are shown.
Adapted from Avezaat and Van Eijndhoven (31). Craniospinal volume–pressure
relationship demonstrating that for the same increase in craniospinal volume
(dV e) the ICP pulse amplitude (dP ) increases when total craniospinal volume
(V e) increases. This is due to the exponential nature of the curve, which is
described mathematically by the equation below the figure, where E 1 is the
elastance coefficient and determines the elastance at a given pressure.
P eq = intracranial equilibrium pressure, P 0 = ICP at zero elastance.
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FIGURE 7 | ICPplse versus ICP relationship [adapted from Avezaat and van Eijndhoven (31)]. ICPplse plotted against ICP, demonstrating a direct linear
relationship. A breakpoint occurs at an ICP of approximately 60 mmHg where the slope of the relationship increases.
severe brain injury because of the associated cardiovascular com-
plications. Therefore, the clinical utility of this technique is limited
unless the pulsatile blood volume can be controlled for.
CEREBRAL AUTOREGULATION
Principles of cerebral autoregulation
As suggested earlier,one of the principle clinical reasons to monitor
ICP is to allow calculation of CPP. This is useful because, in theory,
maintenance of a CPP within the limits of cerebral autoregulation
will result in maintenance of adequate CBF to meet the meta-
bolic demands of the brain (36). Regulation of flow is achieved by
active dilation and constriction of cerebral arterioles in response to
changes of CPP and is illustrated in Figure 8. A number of physi-
ological mechanisms are known to be involved in this process and
Hamner and Tan have recently quantified the relative contribu-
tions of sympathetic, cholinergic and myogenic mechanisms (37).
By measuring CBF while manipulating CPP, and utilizing phar-
macological blockade of the three mechanisms, they were able to
demonstrate the effect that each had on cerebral autoregulation in
healthy volunteers. Of note, they found that 38% of the pressure-
flow relationship was unexplained by these mechanisms, implying
that others must also be important.
The physiological range of autoregulation, is regarded as 50
to 150 mmHg in healthy adults (36). When CPP is below the
lower limit of the autoregulatory range, vessels within the arterial-
arteriolar bed tend to passively vasoconstrict. Conversely, when
CPP is above the upper limit, passive vasodilation occurs. Using
measures of CBF including intra-arterial xenon clearance (38)
and TCD FV of the MCA (39), it has been demonstrated that
FIGURE 8 | Cerebral autoregulation. Illustration of the maintenance of
cerebral blood flow across a range of cerebral perfusion pressures.
disordered cerebral autoregulation occurs after severe TBI and is
associated with worse outcome.
Mathematical models of autoregulation
As discussed above, there is an extensive literature on the math-
ematical modeling of ICP dynamics. Several of these models
incorporate descriptions of cerebral autoregulation. The mod-
els can be primarily physiology based, and aim to improve our
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understanding of the interaction between ICP dynamics and
autoregulation, or they can have a more statistical basis and aim to
provide an index of the state of autoregulation. Examples of each
type of model shall be considered in turn below.
Physiological models of autoregulation
Ursino and Lodi published a simplified mathematical model of the
interaction between ICP and cerebral hemodynamics that is a cut
down version of Ursino’s earlier work (40–42). The model is a two
compartment model, which incorporates the hemodynamics of
the arterial–arteriolar cerebrovascular bed, CSF production, and
reabsorption processes, the pressure–volume relationship of the
craniospinal compartment, and a Starling resistor mechanism for
the cerebral veins (Figure 9). Importantly, it includes a parame-
ter to account for the maximum autoregulatory gain. Using this
model in a series of 20 patients with severe TBI, Ursino et al. were
able to classify the state of cerebral autoregulation and predict the
response of ICP to PVI testing (41).
Czosnyka has also proposed a compartment model of CBF and
CSF circulation (43). It is a three compartment model that consists
of two vascular storage compartments (arterial and venous) and
one CSF storage compartment (Figure 10). Again, this model is
able to simulate the state of autoregulation. Using data taken from
82 patients admitted to ICU with moderate and severe TBI, com-
parison was made between measured clinical responses and simu-
lated model responses to events such as carotid artery compression,
systemic arterial hypotension, and ICH. The mathematical mod-
eling results were found to be helpful with interpretation of the
clinical phenomena. In particular, the model demonstrated that
the correlation between arterial blood pressure (ABP) and ICP is
dependent on the state of autoregulation. Czosnyka exploited this
fact in development of the pressure reactivity index (PRx), which
will be discussed in the following section.
An example of a model bridging the gap between physiologi-
cal and more statistical or data-driven models of autoregulation is
provided by Daley et al. (44). Using a definition of cerebrovascular
pressure transmission provided in the above model by Czosnyka,
the technique of modal analysis was applied. That is, a calcula-
tion of the highest modal frequency (HMF) at which energy is
transferred from ABP to ICP. The HMF is calculated using an
autoregressive moving average (ARMAX) technique and has been
tested in a piglet model of raised ICP. It was found that when cere-
bral autoregulation was intact, a rise in CPP led to a decrease in
HMF. In contrast, when there was autoregulatory impairment, a
rise in CPP was met with an increase in HMF (Figure 11). Simi-
lar results have been seen in patients admitted to ICU with severe
TBI (45).
Data-driven indices of cerebral autoregulation
The most systematically investigated statistical approaches to
autoregulatory assessment, using ICP as an input parameter, is the
PRx described by Czosnyka et al. (46). It is based on the hypoth-
esis that naturally occurring slow oscillations of ABP can be used
to evaluate the cerebrovascular reactivity. In theory, when pressure
reactivity is intact, an increase in ABP would result in cerebral vaso-
constriction and a reduction in ICP (negative PRx). Conversely,
when pressure reactivity is absent, an increase in ABP would result
in a passive rise in ICP (positive PRx). Pressure reactivity has a
complex relationship with cerebral autoregulation rather than the
expressions being analogous.
The PRx is a moving correlation coefficient between 40 consec-
utive samples of values for ABP and ICP averaged over a period
of 5 s. By employing this averaging interval, most of the frequency
changes above 0.2 Hz in the ABP and ICP recordings are filtered
out. In addition, Nyquist’s sampling theorem dictates that the
highest frequency that can be represented by a signal sampled
FIGURE 9 | Electrical equivalence circuit of the Ursino model (42). CBF (q)
enters the intracranial space at systemic arterial pressure (P a). It is subject to
arterial resistance (Ra) and the cerebrovascular bed has some storage
capacity (C a). CBF is then through proximal (Rpv) and distal (Rdv) venous
resistance. Venous pressure (P v) is assumed to equal ICP (P ICP). P ICP is
dependent upon the volume stored in intracranial compliance (C IC). This is
dependent upon blood volume in C a, CSF inflow (q f) through inflow
resistance (R f), and CSF outflow (qo) through outflow resistance (Ro), which is
itself dependent upon venous sinus pressure (P vs). The system can be
disturbed by mock CSF injection (I i).
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FIGURE 10 | Electrical equivalent circuit of the Czosnyka model (43). This
figure Illustrates the presence of three storage compartments
(C a = compliance of the great cerebral arteries, C v = compliance of capillaries,
and small veins, C i = compliance of the CSF containers). Other parameters
are arterial blood pressure (ABP), cerebral arterial pressure in the small
arteries (P a), pressure in the cortical veins (P v), ICP (P i), sagital sinus pressure
(P ss), resistance of great cerebral arteries (Ra), cerebrovascular resistance
(CVR), resistance of cortical and bridging veins (Rb), CSF outflow resistance
(RCSF), and CSF secretion (I t). The lower figure shows the autoregulatory
relationship between CVR and CPP as predicted by the model.
FIGURE 11 | Examples of the relationships between HMF and
CPP during challenge with norepinephrine before and after fluid
percussion injury (FPI). (A) Before FPI. Challenge with
norepinephrine resulted in a response consistent with active
vasoconstriction in that a negative correlation value (R= -0.77) and
negative slope (m) of the regression line (m= -0.317 Hz/mmHg)
between HMF and CPP were demonstrated. (B) After FPI.
Consistent with passive vasodilation, challenge with norepinephrine
resulted in positive correlation values (R=0.34) and slope of
regression line (m=0.325).
every 5 s is 0.1 Hz or 6 oscillations/min. As a result, the dynami-
cal system relationship between ABP and ICP cannot be precisely
defined by PRx.
Nevertheless, PRx has been found to be a very useful tool in
clinical research. In TBI, it has been demonstrated to provide a
reliable index of cerebral autoregulation as validated by TCD (46)
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and PET (47) derived measurements. Clinical observations show
that the PRx is high both during the occurrence of plateau waves
and also during refractory raised ICP (48). In addition, the PRx
has been used to guide proposed therapies and calculation of an
“optimal CPP” for the management of patients with TBI (49).
Comparison of mathematical models of cerebral autoregulation
Despite illustrating a number of the approaches that can be taken,
this is by no means an exhaustive list of models of CBF autoreg-
ulation. It is not clear which approach is most clinically practical
or useful. The models take different input parameters and yield
different output indices, thus making comparison difficult. In an
attempt to address this issue, Shaw et al. re-worked and normal-
ized three of the models so that a fair evaluation could be made
on a standardized dataset of ABP, ICP, and MCA FV readings
taken from piglets pre- and post-fluid percussion injury (50, 51).
The state of autoregulation predicted by the models could then
be compared to changes in pial artery diameter as a direct mea-
sure of autoregulation. One of the interesting conclusions from
this work was that before application of a number of optimiza-
tion approaches, none of the models performed particularly well.
Overall, Ursino’s physiological model performed best and after
optimization of the data-driven models, Daley’s HMF autoregu-
latory index performed marginally better than Czosnyka’s PrX.
This work is limited by the use of only one small dataset for
comparison. What is certain, however, is that further studies com-
paring autoregulatory methods and optimization approaches are
warranted before widespread clinical adoption of a standardized
autoregulation model is possible.
In recognition of this challenge, an international group of those
working in both experimental and clinical autoregulation research
have setup a new consortium called the “Cerebral Autoregulation
Network” or CAR-Net (52).
CURRENT CONTROVERSIES
SHOULD ICP BE MONITORED IN SEVERE TBI?
Monitoring of ICP has become a standard of care in severe TBI
and its use is supported by internationally applied guidelines. The
Brain Trauma Foundation recommends that ICP should be mon-
itored in all salvageable patients with severe TBI and an abnormal
computed tomography (CT) scan (53). Further, they recommend
that monitoring should then be used to target ICP <20 mmHg
and CPP 50–70 mmHg.
The evidence for and against ICP monitoring in TBI has been
appraised in several excellent reviews (54–56). Supporting the
use of ICP monitoring are retrospective comparisons of historical
cohorts at the same center suggesting that protocols incorporat-
ing ICP monitoring improve outcome (57, 58). Similarly, there
has been an association between centers monitoring ICP more
frequently and better outcome (59). In contrast, a retrospective
comparison of two trauma centers revealed an increase in ther-
apy levels without an improvement in outcome in the center that
monitored ICP (60).
On the basis of the wealth of conflicting evidence, there was
demand for an RCT to assess the impact of ICP monitoring on
clinical outcomes. An RCT of 324 patients with severe TBI was sub-
sequently performed in Latin America (5). Patients were assigned
to protocolized therapy directed by either ICP monitoring or clin-
ical examination and imaging. There was no difference between
groups in the primary outcome of a composite of survival time,
impaired consciousness, and functional status at 3 and 6 months
and neuro-psychological status at 6 months.
This study has been subject to extensive discussion and editor-
ial review (61–64) by the lead investigator (65). Irrespective of the
applicability of the findings to the routine practice of ICP moni-
toring in severe TBI, the results certainly strengthen the argument
for more clearly defining the use of ICP targeting strategies as
part of an individualized and multimodal approach to this patient
group.
WHAT MODALITY SHOULD BE USED TO MONITOR ICP?
Introduction
The two techniques most commonly used in clinical practice
to monitor ICP are via an intraventricular or intraparenchymal
catheter with a microtransducer system. Both of these techniques
are invasive and are thus associated with complications such as
hemorrhage and infection. For this reason, significant research
effort has been directed toward development of a non-invasive
method to measure ICP.
Intraventricular catheter
Following Lundberg’s description of the use of intraventricular
catheters for the continuous measurement of CSF pressure (8),
the technique has remained the gold standard for ICP monitoring
(66). It is performed by inserting a catheter into either lateral ven-
tricle through a frontal burr hole. In 1960, Lundberg was already
using electronic measurement equipment by connecting the ven-
tricular cannula via a strain gage transducer to a potentiometer
recorder (Figure 12). In modern practice, the ventricular catheter
can similarly be connected to an external strain gage or the ICP
waveform can be transduced via fibreoptic or micro-strain-gauges
within the catheter itself.
An advantage of measuring ICP using an intraventricular
catheter is the opportunity to perform drainage of CSF as an ICP
lowering therapy. It is also possible to recalibrate the monitor while
FIGURE 12 | Image from Lundberg’s 1960 publication on Continuous
recording and control of ventricular fluid pressure in neurosurgical
practice (8).
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in situ and thus retain accuracy for several days of monitoring.
However, as suggested above, the technique is not without risk. It
can be technically difficult in the case of ventricular effacement or
midline shift. There is a risk of CSF infection but this can be kept
to as low as 10% with a “Bundle” based approach to care (67). The
incidence of hemorrhage following ventriculostomy is around 1%,
although the number requiring surgical evacuation is likely to be
lower (66).
Intraparenchymal catheter
In cases where intraventricular ICP monitoring is not possible, or
in many centers as the preferred technique, an intraparenchymal
device can be placed. The principle difference with the intra-
parenchymal devices is the inability to recalibrate them follow-
ing insertion with the consequent problem of zero drift. Bench
testing of devices using both fibreoptic tips (Camino OLM ICP
monitor; Camino Laboratories, San Diego, CA, USA) and micro-
strain-gauges (Codman Microsensor ICP Transducer; Codman &
Shurtlef Inc., Randolph, MA, USA) have shown 24 h zero drift
of <0.8 mmHg (68). Similarly, laboratory testing of an intra-
parenchymal device incorporating a micro-strain-gauges with a
complete Wheatstone bridge circuit incorporated into the tip
(Raumedic AG,Münchberg,Germany),demonstrated a mean zero
drift of 0.6 mmHg at 5 days (69). However, in the more demanding
clinical environment, a multicentre evaluation concluded that the
zero drift rate remained a concern and catheter performance was
similar to that of other manufacturers (70).
Intraparenchymal ICP monitoring devices are typically placed
via a small burr hole into the white mater of the non-dominant
frontal hemisphere. These devices measure a compartmental-
ized local pressure and significant supratentorial pressure gra-
dients have been demonstrated between monitoring ipsi- and
contralateral to the side of focal hematomas (71).
Non-invasive ICP monitoring
For a non-invasive measure of ICP to replace the commonly used
invasive measures above, it must provide an accurate absolute mea-
sure of ICP that can be performed continuously at the bedside.
There is no current technique that satisfies these criteria. An in
depth review of all of the available technologies is out with the
scope of this article and has been covered in detail elsewhere (72–
74). Techniques considered include imaging based studies using
CT and magnetic resonance imaging (MRI), TCD sonography,
near-infrared spectroscopy (NIRS), tympanic membrane displace-
ment (TMD), visual-evoked potentials (VEPs), measurements of
optic nerve sheath diameter (ONSD), and other measurements of
the optic nerve, retina, and pupil. Of these, approaches using TCD
and ONSD have perhaps received the most clinical interest.
Using low frequency TCD, it is possible to measure FV in
the MCA (75). Several authors have published equations using
the MCA FV metrics of peak systolic velocity (PSV), mean FV
(mFV), end diastolic velocity (EDV), and pulsatility index (PI,
PSV–EDV/mFV) to estimate ICP and CPP.
Schmidtt et al. examined 25 patients admitted with
severe TBI and calculated non-invasive CPP (nCPP) as
MAP× EDV/mFV+ 14 mmHg (76). For these patients, 81%
of 1 min averages of nCPP (n= 12 275) were different from
invasively measured CPP (iCPP) by <10 mmHg. In 81 brain-
injured patients, including 21 with TBI, Bellner et al. calculated
non-invasive ICP (nICP) as 10.93×PI− 1.28 (77). Bland and
Altman analysis of all measurements (n= 658) revealed that
the difference between nICP and invasively measured ICP was
<4.2 mmHg for 95% of measurements. Edouard et al. calculated
nCPP as [mFV/(mFV− EDV)]× (MAP−DAP) in patients with
severe TBI and bilateral injury (78). In 10 patients, repeated mea-
surements were made during their clinical course (n= 89) and a
significant correlation was found between nCPP and iCPP. How-
ever, in a further 10 patients in whom hypercapnia was induced,
the strength of this correlation was reduced.
The performance of the above three equations in estimating
ICP was compared in 45 patients with severe TBI by Brandi
et al. (79). Under standardized conditions, including continuous
sedation, normocapnia and normothermia, daily nICP measure-
ments were compared to ICP measured using an intraparenchymal
device. On the basis of Bland and Altman analysis, the authors
concluded that the equation by Bellner et al. (77) was superior
in assessing nICP. However, as has been noted elsewhere (54), the
Bellner equation failed to predict all cases of ICH in this series
and is therefore not likely to be clinically useful as a screening test
in TBI.
Like TCD measurements, assessment of ONSD using ultra-
sound potentially provides a simple bedside screening test for ICH
in TBI. The technique exploits the fact that the optic nerve is part of
the central nervous system and therefore, a rise in ICP will be trans-
mitted through the CSF surrounding the nerve. Several studies
comparing ultrasound derived ONSD assessment to iICP (80–85)
have been included in a recent meta-analysis (86). This was lim-
ited by the fact that it included only 231 patients, 89 of whom
had suffered TBI. However, using the ONSD thresholds reported
in the individual studies, the pooled sensitivity and specificity to
detect ICH were 90 and 85%, respectively. Dubourg et al. are now
collecting data for an individual patient data meta-analysis with
the objective of defining the cut-off value for ultrasound-derived
ONSD in the detection of ICH (87).
SHOULD ICP OR CPP BE THE TARGET?
Whatever modality is chosen to monitor ICP in severe TBI, the
clinician must then decide whether to primarily target therapy at
attempting to optimize CPP or lower ICP. CPP oriented therapy,
as proposed by Rosner et al. (88), requires pressure autoregulation
and the ability to manipulate CPP within the autoregulatory range.
During intact pressure regulation, increases of CPP cause constric-
tion of the arterial–arteriolar vascular bed and lowering of ICP
by a reduction in cerebral blood volume. In addition, the result-
ing reduction of pre- and post-capillary pressure decreases fluid
filtration and increases absorption, thus reducing brain edema.
However, the application of CPP oriented therapy when autoreg-
ulation has been lost may result in an imbalance of Starling forces
at the capillaries leading to increased net fluid filtration and further
brain injury by increased production of vasogenic edema.
Avoiding vasogenic edema is one of the underlying tenets of the
“Lund” approach to management of severe TBI based on lowering
ICP (89,90). Asgeirsson et al.,working at the University Hospital of
Lund, described a protocol aimed at inducing transcapillary fluid
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absorption through reduction of hydrostatic capillary pressure and
preservation of normal colloid osmotic pressure. This included
pharmacological interventions such as the reduction of systemic
hypertension with metoprolol and clonidine, and precapillary
vasoconstriction with dihydroergotamine.
In an attempt to determine whether an ICP or CPP based
approach was preferable, Roberston et al. conducted an RCT in
189 patients admitted with severe TBI. Patients were randomized
to an ICP based protocol or a CBF based protocol. The major dif-
ferences between the protocols were the CPP targets (>50 mmHg
in the ICP group and >70 in the CBF group) and the option to
treat ICH with hyperventilation in the ICP group. In terms of the
primary outcome of this study, cerebral ischemia as measured by
jugular venous desaturations, the CBF based protocol was associ-
ated with a lower risk of ischemia. However, this did not translate
into improved neurological outcome and indeed was associated
with an increased frequency of systemic complications such as
adult respiratory distress syndrome (ARDS).
It is likely that the choice of ICP or CPP based approach to
ICU management of severe TBI should be made on an individual
patient basis. For this to be possible, the state of autoregulation
needs to be assessed.
Support for the clinical utility of a PRx type index has been pro-
vided by Howells et al. (91). The approach of two neurosurgical
ICUs to ICP management in TBI was compared using a PRx-based
index, averaged over many hours per day, and a machine learning
Bayesian Neural Network (BANN) model, which predicted the
probability of good or bad clinical outcome. In one center, the pre-
dominant management approach was CPP-targeted therapy and
in the other, the approach was ICP-targeted therapy. The model
showed that not only pressure reactivity was related to clinical out-
come but also that its relationship to outcome was management
approach dependent (Figure 13). From this data, a principally
CPP-targeted approach was more successful when pressure reac-
tivity was intact, while a principally ICP targeted approach was
more successful when pressure reactivity was impaired. Of course,
there could be other factors influencing clinical outcome that
were not considered in the analysis. Nevertheless, it is compelling
evidence for what appears to be common sense: a management
strategy that considers the brains’ ability to regulate its blood flow
is more successful than one that does not.
FUTURE DIRECTIONS
INTRODUCTION
The field of ICP research is a wide ranging one and, to date,
has been the subject of 15 international symposia embracing
such diverse disciplines as neurosurgery, intensive care, anesthe-
sia, radiology, biophysics, electronic and mechanical engineering,
mathematics, and computer science (92). This multidisciplinary
and collaborative approach is highlighted by research groups such
as International Mission for Prognosis and Analysis of Clinical
Trials in TBI (IMPACT) (93), Brain Monitoring with Information
Technology (BrainIT) (94), and the recently funded CENTER-TBI
project (95).
At present, there is no level 1 evidence to support the target-
ing of a specific ICP or CPP using clinical interventions. This
may change with ongoing RCT. For example, Eurotherm3235 is
FIGURE 13 | BANN generated probability distribution plots for the
mean likelihood of a favorable clinical outcome for patient populations
managed in two different centers. In this data, the optimal point at which
to switch from one treatment strategy to the other in a given patient is at
an MABP/ICP trend with a slope of approximately 0.13. Taken from Howells
et al. (91).
assessing titrated hypothermia to treat ICH (79, 80) and RES-
CUEicp is evaluating the role of decompressive craniectomy in
treatment of uncontrollable ICH (96). In parallel to these trials,
there is considerable effort to extract more information, rather
than simply a generic threshold value, from the ICP signal and use
this to provide patient-specific targets and to forecast secondary
ICP insults. In addition, there is ongoing effort to develop novel
non-invasive techniques to measure ICP and thus widen its clinical
application. Some key areas of current research shall be discussed
below.
INDIVIDUALIZED ICP AND CPP TARGETS
As an alternative to using a universal CPP threshold for all TBI
patients, a more dynamic patient tailored CPP target, based upon
the autoregulation capacity of the cerebral vasculature, has been
proposed. In retrospective analysis, Steiner et al. (49) demon-
strated that by plotting PRx against CPP for the entire monitoring
period, a “U-shaped” curve could be produced in about 60% of
patients. The CPP corresponding to the minimum PRx was taken
to represent the optimal CPP (CPPopt) for each patient. Patients
who were managed with CPPs closer to CPPopt were more likely
to have a good outcome.
The feasibility of using PRx to prospectively calculate CPPopt
in TBI patients in a clinical environment has subsequently been
demonstrated by Aries et al. (97). Using a 4-h moving window,
updated every minute, CPPopt could be calculated for 55% of the
monitoring period. Again, patients were more likely to have a good
outcome if their actual CPP deviated less from CPPopt.
In similar work, Lazaridis et al. (98) have used PRx to identify
patient-specific ICP thresholds in TBI. By plotting PRx against ICP
for the entire monitoring period, the threshold ICP was taken to
be that at which the PRx was consistently >0.2. It was possible to
calculate a threshold ICP in 68% of patients. Time spent above an
individually calculated ICP threshold was more strongly predic-
tive of mortality than using a generic threshold of 20 or 25 mmHg.
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This further supports the concept of patient-specific targets of ICP
or CPP in the management of TBI.
However, calculation of PRx and most other measures of
autoregulation require high frequency data (>50 Hz) sampling.
Capturing and processing this data frequency is not routine in
many NICUs. Consequently,Depretiere et al. have developed a new
index of cerebrovascular reactivity that requires only minute-by-
minute data sampling (99). Known as LAx, the index is the moving
median of minute-by-minute ICP/MAP correlation coefficients
over different time intervals (3–120 min). They demonstrated that
not only does it correlate with PRx and GOS but also is able to pro-
duce a CPPopt recommendation. DATACAR (Dynamic Adaptive
Target of Cerebral Autoregulation) combines different LAx values
and time windows in a weighted manner to issue a CPPopt rec-
ommendation (Figure 14). They observed significant differences
between PRx-based and LAx-based CPPopts. DATACAR was able
to issue a CPPopt recommendation in 92% of monitoring time, as
opposed to 44% for PRx-based CPPopt.
Certainly, a method for continuous and robust determination
of a patient’s optimal CPP that can work with normal NICU data
capture rates, is an attractive concept. A prospective study compar-
ing a number of these indices is warranted. These developments
show clearly the benefits possible through the combination of shar-
ing and analysis of large ICU datasets with the development and
application of mathematical models.
PREDICTION OF SECONDARY ICP INSULTS
An interesting approach to forecasting ICH is based on preceding
changes to waveform morphology. In recognition that most clini-
cal decision making only takes into account the mean ICP, Hu and
colleagues have proposed a technique for automatically extracting
useful information from the ICP waveform (100). Morphologi-
cal clustering and analysis of continuous ICP (MOCAIP) detects
the P1, P2, and P3 peaks within the ICP waveform. The tech-
nique was developed and validated using an annotated database
of ICP waveforms collected from 66 patients admitted to an adult
hydrocephalus center. For every 3 min section of ICP recording,
the MOCAIP algorithm performs beat-by-beat pulse detection
followed by pulse clustering to generate a dominant ICP pulse.
Artifactual pulses are removed prior to the detection and optimal
designation of pulse peaks. This process has been generalized as
MOCAIP++ and validated on a larger dataset collected from 128
patients (101).
The application of MOCAIP to ICP monitoring in TBI has
been demonstrated (102). In a dataset from 66 patients, includ-
ing 23 admitted with TBI, ICP pulse morphological metrics were
correlated with low CBF as measured by an intravenous 133Xenon
clearance technique. Of particular interest, was the association of
an elevated P3 peak and low CBF. However, in this study, the cor-
relation of pulse morphological metrics to low CBF was less in the
TBI patients than in those admitted with other diagnoses such as
subarachnoid hemorrhage.
In the first efforts to use MOCAIP analysis to forecast episodes
of elevated ICP, an ICP waveform dataset recorded from 34
patients presenting with suspected idiopathic ICH, CSF shunts,
and Chiari malformation was evaluated (103). Using 24 metrics
of the ICP waveform, it was possible to classify recording segments
as either control or pre-IH prior to episodes of elevation of ICP
to >20 mmHg over a period of at least 20 min. This was done
with a sensitivity of 37 and 21% and specificity of 99 and 99%
for 5 and 20 min, respectively. These results are encouraging but
may not generalize to TBI because of the difference in underlying
pathophysiological mechanisms.
An alternative approach to prediction of ICH, which has been
developed using data collected from patients admitted to NICU
with TBI, is through the use of Gaussian processes (104). Using
4 h windows of minute-by-minute recordings of ICP and MAP,
Guiza et al. generated over 1000 potential dynamic predictors
from which a subset of 73 was selected. These included median
values for non-overlapping time intervals, measures of variability,
clustering of values based on their trajectory, frequency domain
analysis, and correlation of ICP with MAP. Gaussian processes are
FIGURE 14 | Example of an optimal CPP range (CPPopt) derived from the most recent 4-h CPP and autoregulation index values.
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a machine-learning algorithm that generates a probabilistic pre-
diction based on the known outcomes of similar data instances.
The model was developed in a cohort of 178 patients to predict
30 min in advance of an elevation of ICP to >30 mmHg over a
period of at least 10 min. It was then evaluated in a further cohort
of 61 patients achieving a sensitivity of 82% and specificity of 75%.
Future predictive models may incorporate both ICP wave-
form features and dynamic predictors to optimize their predictive
capacity. The value of these predictions would then need to be
assessed by providing them to clinicians and formally assessing
the impact on patient management and outcome.
INNOVATIVE NON-INVASIVE ICP MONITORING
As suggested above, no methodology in current clinical use pro-
vides an accurate absolute measure of ICP. A novel technique,
which provides an absolute value of ICP, has recently been
described by Raguaskas et al. (105). A two-depth TCD device is
used to identify the intracranial and extracranial components of
the ophthalmic artery (IOA and EOA). Following the assumption
that the Doppler waveform of the IOA is dependent on compres-
sion by ICP and that of the EOA by externally applied pressure
(Pe), a ring cuff is applied to the orbit and automatically inflated
from 0 to 28 mmHg in 4 mmHg steps. The Pe at which the wave-
forms of the IOA and EOA are identical is taken to represent
the ICP. A comparison study of this technique to CSF pressure
measured by lumbar puncture was performed in 62 patients pre-
senting to a neurology clinic, including 37 with suspected IIH and
20 with multiple sclerosis. For invasively measured CSF pressures
in the range of 4–24, the non-invasive technique achieved a 98%
confidence interval for the absolute error of ±4 mmHg.
In a study of a similar group of patients, the two-depth TCD
technique was compared to the ONSD technique in its ability to
predict raised CSF pressure as measured by LP (106). Using a
CSF pressure threshold of 14.7 mmHg, and an ONSD cut-off of
5 mm, the two-depth TCD technique outperformed the ONSD
technique with sensitivities of 68 and 37% and specificities of 84
and 59%. Clearly, neither of these techniques could be used for
clinical decision making at these thresholds.
Further work is required to confirm the safety of the innovative
two-depth TCD technique in terms of pressure effects on the globe
and exposure of the lens to Doppler US. The applicability of the
technique to the TBI population and across a wider range of ICP
values has yet to be demonstrated.
CONCLUSION
Despite the fact that ICP monitoring in TBI has become a standard
of care, there is no level 1 evidence to support its use in targeting
generic ICP thresholds. However, there can be little doubt that
investigation of ICP and the ICP–volume relationship has led to
an improved understanding of cerebral physiology. It is now time
to exploit this knowledge and integrate ICP monitoring into a
multimodality and individualized approach to care. Future RCTs
of ICP monitoring should utilize autoregulatory assessment to
provide patient-specific thresholds for ICP and CPP. The use of
non-invasive monitors of ICP is an attractive prospect but not yet
supported by the technology.
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